{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:22:10Z","timestamp":1792801330911,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,12,22]],"date-time":"2004-12-22T00:00:00Z","timestamp":1103673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s00213-004-2095-0","type":"journal-article","created":{"date-parts":[[2004,12,21]],"date-time":"2004-12-21T16:03:32Z","timestamp":1103645012000},"page":"597-605","source":"Crossref","is-referenced-by-count":27,"title":["Effects of the antidepressant trazodone, a 5-HT2A\/2C receptor antagonist, on dopamine-dependent behaviors in rats"],"prefix":"10.1007","volume":"179","author":[{"given":"Jehangir J.","family":"Balsara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata A.","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajani K.","family":"Gaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona V.","family":"Gaikwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdish H.","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,12,22]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.2042-7158.1980.tb13066.x","volume":"32","author":"T Alander","year":"1980","unstructured":"Alander T, Grabowska-Anden M, Anden NE (1980) Physiological significance of dopamine autoreceptors as studied following their selective blockade by molindone. J Pharm Pharmacol 32:780\u2013782","journal-title":"J Pharm Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00427514","volume":"64","author":"JJ Balsara","year":"1979","unstructured":"Balsara JJ, Jadhav JH, Muley MP, Chandorkar AG (1979a) Effect of drugs influencing central serotonergic mechanisms on methamphetamine-induced stereotyped behavior in the rat. Psychopharmacology 64:303\u2013307","journal-title":"Psychopharmacology"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00426037","volume":"62","author":"JJ Balsara","year":"1979","unstructured":"Balsara JJ, Jadhav JH, Chandorkar AG (1979b) Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy. Psychopharmacology 62:67\u201369","journal-title":"Psychopharmacology"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/BF00432262","volume":"78","author":"JJ Balsara","year":"1982","unstructured":"Balsara JJ, Bapat TR, Gada VP, Chandorkar AG (1982) Small doses of apomorphine induce catalepsy and antagonise methamphetamine stereotypy in rats. Psychopharmacology 78:192\u2013194","journal-title":"Psychopharmacology"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00180824","volume":"88","author":"JJ Balsara","year":"1986","unstructured":"Balsara JJ, Bapat TR, Nandal NV, Gada VP, Chandorkar AG (1986) Head-twitch response induced by ergometrine in mice: behavioural evidence for direct stimulation of central 5-hydroxytryptamine receptors by ergometrine. Psychopharmacology 88:275\u2013278","journal-title":"Psychopharmacology"},{"key":"CR6","first-page":"108","volume":"17","author":"TR Bapat","year":"1985","unstructured":"Bapat TR, Gada VP, Nandal NV, Balsara JJ, Chandorkar AG (1985) Behavioural evidence for direct stimulation of rat brain 5-hydroxytryptamine receptors by ergometrine. Indian J Pharmacol 17:108\u2013112","journal-title":"Indian J Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02253718","volume":"101","author":"HHG Berendsen","year":"1990","unstructured":"Berendsen HHG, Jenck F, Broekkamp CLE (1990) Involvement of 5-HT1C receptors in drug-induced penile erections in rats. Psychopharmacology 101:57\u201361","journal-title":"Psychopharmacology"},{"key":"CR8","unstructured":"Berendsen HHG, Broekkamp CLE, Popping JMP (1992) Fluoxetine familiarizes with a 5-HT1C, but not with a 5-HT1A or 5-HT2 receptor agonist. 2nd Int symposium on serotonin, from cell biology to pharmacology and therapeutics, Houston, Abstract, p 55"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-1-4684-5191-7_10","volume-title":"Neurobiology of central D-1 dopamine receptors","author":"AR Braun","year":"1986","unstructured":"Braun AR, Barone P, Chase TN (1986) Interaction of D-1 and D-2 dopamine receptors in the expression of dopamine agonist induced behaviors. In: Breese GR, Creese I (eds) Neurobiology of central D-1 dopamine receptors. Plenum Press, New York, pp 151\u2013166"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0028-3908(81)90131-3","volume":"20","author":"CJ Carter","year":"1981","unstructured":"Carter CJ, Pycock CJ (1981) The role of 5-hydroxytryptamine in dopamine-dependent stereotyped behaviour. Neuropharmacology 20:261\u2013265","journal-title":"Neuropharmacology"},{"key":"CR11","first-page":"61","volume":"31","author":"A Chodera","year":"1981","unstructured":"Chodera A, Cenajek D, Mazurek K (1981) Interaction of parachlorophenylalanine, mianserine and danitracen with amphetamine. Arzneimittelforschung 31:61\u201363","journal-title":"Arzneimittelforschung"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0028-3908(80)90197-5","volume":"19","author":"S Clements-Jewery","year":"1980","unstructured":"Clements-Jewery S, Robson PA, Chidley LJ (1980) Biochemical investigations into the mode of action of trazodone. Neuropharmacology 19:1165\u20131173","journal-title":"Neuropharmacology"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0028-3908(83)90148-X","volume":"22","author":"P Conway","year":"1983","unstructured":"Conway P, Uretsky NJ (1983) Enhanced stereotyped response to amphetamine after pretreatment with small doses of molindone. Neuropharmacology 22:579\u2013586","journal-title":"Neuropharmacology"},{"key":"CR14","first-page":"225","volume-title":"The biochemical basis of neuropharmacology","author":"JR Cooper","year":"2003","unstructured":"Cooper JR, Bloom FE, Roth RH (2003) The biochemical basis of neuropharmacology, 8th edn. Oxford University Press, New York, pp 225\u2013270","edition":"8"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0014-2999(74)90201-5","volume":"27","author":"B Costall","year":"1974","unstructured":"Costall B, Naylor RJ (1974) Mesolimbic involvement with behavioural effects indicating antipsychotic activity. Eur J Pharmacol 27:46\u201358","journal-title":"Eur J Pharmacol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0306-4522(98)00655-1","volume":"91","author":"G Giovanni Di","year":"1999","unstructured":"Di Giovanni G, De Deurwaerdere P, Di Mascio M, Di Matteo V, Esposito E, Spampinato U (1999) Selective blockade of serotonin2C\/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience 91:587\u2013597","journal-title":"Neuroscience"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0028-3908(99)00047-7","volume":"38","author":"V Matteo Di","year":"1999","unstructured":"Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E (1999) SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology 38:1195\u20131205","journal-title":"Neuropharmacology"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0006-8993(00)02246-0","volume":"865","author":"V Matteo Di","year":"2000","unstructured":"Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E (2000a) Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors. Brain Res 865:85\u201390","journal-title":"Brain Res"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s002130000420","volume":"150","author":"V Matteo Di","year":"2000","unstructured":"Di Matteo V, Di Mascio M, Di Giovanni G, Esposito E (2000b) Acute administration of amitriptyline and mianserin increases dopamine release in the rat nucleus accumbens: possible involvement of serotonin2C receptors. Psychopharmacology 150:45\u201351","journal-title":"Psychopharmacology"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1096-9861(19970728)384:2<233::AID-CNE5>3.0.CO;2-2","volume":"384","author":"K Eberle-Wang","year":"1997","unstructured":"Eberle-Wang K, Mikeladze Z, Uryu K, Chesselet MF (1997) Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats. J Comp Neurol 384:233\u2013247","journal-title":"J Comp Neurol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0091-3057(97)00292-X","volume":"58","author":"DJ Feldman","year":"1997","unstructured":"Feldman DJ, Frank RA, Kehne JH, Flannery R, Brown D, Soni S, Byrd G, Shah S (1997) Mixed D2\/5-HT2 antagonism differentially affects apomorphine- and amphetamine-induced stereotyped behavior. Pharmacol Biochem Behav 58:565\u2013572","journal-title":"Pharmacol Biochem Behav"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0014-2999(83)90609-X","volume":"89","author":"E Friedman","year":"1983","unstructured":"Friedman E, Cooper TB, Dallob A (1983) Effects of chronic antidepressant treatment on serotonin receptor activity in mice. Eur J Pharmacol 89:69\u201376","journal-title":"Eur J Pharmacol"},{"key":"CR23","first-page":"2482","volume-title":"Kaplan and Sadock\u2019s Comprehensive textbook of psychiatry, vol 2","author":"SJ Garlow","year":"2000","unstructured":"Garlow SJ, Nemeroff CB (2000) Trazodone. In: Sadock BJ, Sadock VA (eds) Kaplan and Sadock\u2019s Comprehensive textbook of psychiatry, vol. 2, 7th edn. Lippincott Williams and Wilkins, Philadelphia, pp 2482\u20132490","edition":"7"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1098-2396(20000601)36:3<205::AID-SYN5>3.0.CO;2-D","volume":"36","author":"A Gobert","year":"2000","unstructured":"Gobert A, Rivet JM, Lejeune F, Newman-Tancredi A, Adhumeau-Auclair A, Nicolas JP, Cistarelli L, Melon C, Millan MJ (2000) Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 36:205\u2013221","journal-title":"Synapse"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0014-2999(94)90669-6","volume":"264","author":"GA Gudelsky","year":"1994","unstructured":"Gudelsky GA, Yamamoto BK, Nash JF (1994) Potentiation of 3, 4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists. Eur J Pharmacol 264:325\u2013330","journal-title":"Eur J Pharmacol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF02246184","volume":"120","author":"DC Hoffman","year":"1995","unstructured":"Hoffman DC, Donovan H (1995) Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability. Psychopharmacology 120:128\u2013133","journal-title":"Psychopharmacology"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1111\/j.1471-4159.1992.tb10975.x","volume":"58","author":"J Ichikawa","year":"1992","unstructured":"Ichikawa J, Meltzer HY (1992) Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens. J Neurochem 58:2285\u20132291","journal-title":"J Neurochem"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(93)90453-O","volume":"231","author":"F Jenck","year":"1993","unstructured":"Jenck F, Moreau JL, Mutel V, Martin JR, Haefely WE (1993) Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs. Eur J Pharmacol 231:223\u2013229","journal-title":"Eur J Pharmacol"},{"key":"CR29","first-page":"334","volume":"30","author":"CS Kandi","year":"1998","unstructured":"Kandi CS, Metkar BR, Kasture VS, Kasture SB (1998) Effect of serotonergic agents on amphetamine induced stereotypy. Indian J Pharmacol 30:334\u2013338","journal-title":"Indian J Pharmacol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s002130050265","volume":"131","author":"G Lucas","year":"1997","unstructured":"Lucas G, Bonhomme N, De Deurwaerdere P, Le Moal M, Spampinato U (1997) 8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A\/2C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release. Psychopharmacology 131:57\u201363","journal-title":"Psychopharmacology"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-2999(84)90090-6","volume":"107","author":"D Luttinger","year":"1985","unstructured":"Luttinger D, Freedman M, Hamel L, Ward SJ Perrone M (1985) The effects of serotonin antagonists in a behavioral despair procedure in mice. Eur J Pharmacol 107:53\u201358","journal-title":"Eur J Pharmacol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0028-3908(94)90058-2","volume":"33","author":"GR Martin","year":"1994","unstructured":"Martin GR, Humphrey PPA (1994) Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology 33:261\u2013273","journal-title":"Neuropharmacology"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/BF00634460","volume":"99","author":"GE Martin","year":"1989","unstructured":"Martin GE, Mathiasen JR, Kesslick JM (1989) Blockade of conditioned avoidance responding by trazodone, etoperidone, and MCPP. Psychopharmacology 99:94\u201397","journal-title":"Psychopharmacology"},{"key":"CR34","first-page":"587","volume":"43","author":"HY Meltzer","year":"1991","unstructured":"Meltzer HY, Nash JF (1991) Effects of antipsychotic drugs on serotonin receptors. Pharmacol Rev 43:587\u2013604","journal-title":"Pharmacol Rev"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0306-4522(96)00452-6","volume":"76","author":"H Moukhles","year":"1997","unstructured":"Moukhles H, Bosler O, Bolam JP, Vallee A, Umbriaco D, Geffard M, Doucet G (1997) Quantitative and morphometric data indicate precise cellular interactions between serotonin terminals and postsynaptic targets in rat substantia nigra. Neuroscience 76:1159\u20131171","journal-title":"Neuroscience"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.npp.1300329","volume":"29","author":"S Navailles","year":"2004","unstructured":"Navailles S, De Deurwaerdere P, Porras G, Spampinato U (2004) In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum. Neuropsychopharmacology 29:319\u2013326","journal-title":"Neuropsychopharmacology"},{"key":"CR37","first-page":"207","volume":"265","author":"BS Neal-Beliveau","year":"1993","unstructured":"Neal-Beliveau BS, Joyce JN, Lucki I (1993) Serotonergic involvement in haloperidol-induced catalepsy. J Pharmacol Exp Ther 265:207\u2013217","journal-title":"J Pharmacol Exp Ther"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0169-328X(94)90223-2","volume":"23","author":"M Pompeiano","year":"1994","unstructured":"Pompeiano M, Palacios JM, Mengod G (1994) Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res 23:163\u2013178","journal-title":"Brain Res Mol Brain Res"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0893-133X(01)00333-5","volume":"26","author":"G Porras","year":"2002","unstructured":"Porras G, Di Matteo V, Fracasso C, Lucas G, De Deurwaerdere P, Caccia S, Esposito E, Spampinato U (2002) 5-HT2A and 5-HT2C\/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology 26:311\u2013324","journal-title":"Neuropsychopharmacology"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/sj.bjp.0702350","volume":"126","author":"C Reavill","year":"1999","unstructured":"Reavill C, Kettle A, Holland V, Riley G, Blackburn TP (1999) Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist. Br J Pharmacol 126:572\u2013574","journal-title":"Br J Pharmacol"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0014-2999(72)90230-0","volume":"20","author":"J Rotrosen","year":"1972","unstructured":"Rotrosen J, Angrist BM, Wallach MB, Gershon S (1972) Absence of serotonergic influence on apomorphine-induced stereotypy. Eur J Pharmacol 20:133\u2013135","journal-title":"Eur J Pharmacol"},{"key":"CR42","first-page":"269","volume-title":"The pharmacological basis of therapeutics","author":"E Sanders-Bush","year":"2001","unstructured":"Sanders-Bush E, Mayer SE (2001) 5-hydroxytryptamine (serotonin): receptor agonists and antagonists. In: Hardman JG, Limbird LE, Gilman AG (eds) The pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York, pp 269\u2013290","edition":"10"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/0024-3205(95)00210-W","volume":"56","author":"CJ Schmidt","year":"1995","unstructured":"Schmidt CJ, Sorensen SM, Kehne JH, Carr AA, Palfreyman MG (1995) The role of 5-HT2A receptors in antipsychotic activity. Life Sci 56:2209\u20132222","journal-title":"Life Sci"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev.pa.33.040193.003231","volume":"33","author":"LS Seiden","year":"1993","unstructured":"Seiden LS, Sabol KE, Ricaurte GA (1993) Amphetamine: effects on catecholamine systems and behaviour. Annu Rev Pharmacol Toxicol 33:639\u2013677","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF02244101","volume":"102","author":"F Wanibuchi","year":"1990","unstructured":"Wanibuchi F, Usuda S (1990) Synergistic effects between D-1 and D-2 dopamine antagonists on catalepsy in rats. Psychopharmacology 102:339\u2013342","journal-title":"Psychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-2095-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-004-2095-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-2095-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:01:24Z","timestamp":1558641684000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-004-2095-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,22]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["2095"],"URL":"https:\/\/doi.org\/10.1007\/s00213-004-2095-0","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,22]]}}}